The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic

<div>Continuation and discontinuation of medications in IBD patients during the COVID-19 epidemic. (a) The number of CD patients who continued and discontinued their medications (5-aminosalicylic acid, glucocorticoid, immunosuppressants, biological agents, and enteral nutrition drugs). (b) The number of UC patients who continued and discontinued their medications.</div>

Journal of Immunology Research

fig1

Figure 1

Figure 1: The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic 